MaxLinear (MXL) director receives 2,052 shares as RSUs fully vest

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MaxLinear, Inc. director Kris Sennesael acquired 2,052 shares of Common Stock through RSU vesting. On May 1, 2026, 100% of a Restricted Stock Unit award vested, and each RSU converted into one share of MaxLinear Common Stock. Following this transaction, Sennesael directly holds 2,052 Common shares. The filing shows a routine compensation-related RSU vesting and derivative exercise with no open-market buying or selling.

Insider Trade Summary

2,052 shares exercised/converted

Mixed 2 txns

Insider Sennesael Kris

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,052	$0.00	--
Exercise	Common Stock	2,052	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 2,052 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.

Key Figures

Shares acquired via RSU vesting: 2,052 shares RSUs converted: 2,052 units Shares held after transaction: 2,052 shares +1 more

4 metrics

Shares acquired via RSU vesting 2,052 shares Common Stock received May 1, 2026

RSUs converted 2,052 units Restricted Stock Units converted into Common Stock

Shares held after transaction 2,052 shares Total direct Common Stock holdings following transaction

Vesting date May 1, 2026 100% of RSUs under the award vested

Key Terms

Restricted Stock Units, contingent right, derivative security

3 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of MaxLinear, Inc. Common Stock"

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Form 4 Insider Transactions: What Each Field Means →

05/05/2026 - 04:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sennesael Kris

(Last)

(First)

(Middle)

C/O MAXLINEAR, INC.

5966 LA PLACE COURT, SUITE 100

(Street)

CARLSBAD

CALIFORNIA

92008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		M		2,052	A	$0	2,052	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/01/2026		M			2,052	⁽²⁾	⁽²⁾	Common Stock	2,052	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.

2. One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.

Remarks:

	/s/ Connie Kwong, as Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MaxLinear (MXL) director Kris Sennesael report?

Kris Sennesael reported acquiring 2,052 shares of MaxLinear Common Stock when Restricted Stock Units vested on May 1, 2026. The RSUs converted into an equal number of shares as part of routine equity compensation, with no open-market purchase or sale involved.

How many MaxLinear (MXL) shares does Kris Sennesael hold after this Form 4?

After the reported transaction, Kris Sennesael directly holds 2,052 shares of MaxLinear Common Stock. These shares were received upon vesting and conversion of 2,052 Restricted Stock Units, reflecting equity compensation rather than open-market trading activity or a discretionary stock purchase.

What happened to the 2,052 Restricted Stock Units reported for MaxLinear (MXL)?

The 2,052 Restricted Stock Units fully vested on May 1, 2026, and each RSU converted into one share of MaxLinear Common Stock. Following this exercise, no RSUs from that award remained outstanding, and the director’s position shifted entirely into Common Stock holdings.

Does this MaxLinear (MXL) Form 4 show any stock sales or purchases?

The Form 4 does not show any open-market stock sales or purchases. It records an RSU vesting event where 2,052 Restricted Stock Units converted into 2,052 shares of MaxLinear Common Stock as equity compensation, leaving the director with 2,052 directly held shares.

How are Restricted Stock Units described in this MaxLinear (MXL) filing?

The filing states each Restricted Stock Unit represents a contingent right to receive one share of MaxLinear Common Stock. In this case, 100% of the RSUs under the award vested on May 1, 2026, triggering delivery of an equal number of Common shares to the director.